Summit Therapeutics to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
August 29 2018 - 6:00AM
Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) announces that Mr
Glyn Edwards, Chief Executive Officer, will present on the
Company’s plans to advance its new mechanism antibiotic pipeline at
the Rodman & Renshaw 20th Annual Global Investment
Conference, sponsored by H.C. Wainwright & Co., LLC, 6
September 2018 at 11:15am EDT in New York City.
A live webcast of the presentation will be
available in the Investors section of the Company's website,
www.summitplc.com. A replay of the webcast will be available from
the same location soon after the live presentation.
About Summit TherapeuticsSummit
Therapeutics is a leader in antibiotic innovation. Our new
mechanism antibiotics are designed to become the new standards of
care for the benefit of patients and create value for payors and
healthcare providers. We are currently developing new mechanism
antibiotics for C. difficile infection and gonorrhoea and are using
our proprietary Discuva Platform to expand our pipeline. For more
information, visit www.summitplc.com and follow us on Twitter
@summitplc.
|
For more information, please contact: |
|
|
|
|
|
Summit |
|
|
|
|
Glyn
Edwards / Richard Pye (UK office) |
|
Tel: |
|
44
(0)1235 443 951 |
Erik
Ostrowski / Michelle Avery (US office) |
|
|
|
+1
617 225 4455 |
|
|
|
|
|
Cairn Financial Advisers LLP (Nominated
Adviser) |
|
Tel: |
|
+44
(0)20 7213 0880 |
Liam
Murray / Tony Rawlinson |
|
|
|
|
|
|
|
|
|
N+1 Singer (Joint Broker) |
|
Tel: |
|
+44
(0)20 7496 3000 |
Aubrey Powell / Jen Boorer |
|
|
|
|
|
|
|
|
|
Panmure Gordon (Joint Broker) |
|
Tel: |
|
+44
(0)20 7886 2500 |
Freddy Crossley, Corporate Finance |
|
|
|
|
James
Stearns, Corporate Broking |
|
|
|
|
|
|
|
|
|
MSL Group (US) |
|
Tel: |
|
+1
617 684 6557 |
Jon
Siegal |
|
|
|
Jon.siegal@mslgroup.com |
|
|
|
|
|
Consilium Strategic Communications (UK) |
|
Tel: |
|
+44
(0)20 3709 5700 |
Mary-Jane Elliott / Jessica Hodgson |
|
|
|
summit@consilium-comms.com |
/
Lindsey Neville |
|
|
|
|
Summit Therapeutics (NASDAQ:SMMT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Summit Therapeutics (NASDAQ:SMMT)
Historical Stock Chart
From Jul 2023 to Jul 2024